Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy
Abstract Purpose/Objectives Most patients with pancreatic adenocarcinoma (PDAC) will present with distant metastatic disease at diagnosis. We sought to identify clinical characteristics associated with prolonged overall survival (OS) in patients presenting with metastatic PDAC. Materials/Methods Pat...
Main Authors: | Saryleine deOrtiz de Choudens, Alexis Visotcky, Anjishnu Banerjee, Mohammed Aldakkak, Susan Tsai, Douglas B. Evans, Kathleen K. Christians, Callisia N. Clarke, Ben George, Aditya Shreenivas, Mandana Kamgar, Sakti Chakrabarti, Kulwinder S. Dua, Abdul Haq Khan, Srivats Madhavan, Beth A. Erickson, William A. Hall |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6582 |
Similar Items
-
Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
by: Carole Mercier, et al.
Published: (2022-04-01) -
Modern approach in oligometastatic prostate cancer therapy
by: Stanić Jelena, et al.
Published: (2023-01-01) -
Therapy of Locally Advanced and Oligometastatic Pancreatic Adenocarcinoma
by: Isabell Luisa Wahler, et al.
Published: (2023-12-01) -
Brachytherapy for oligometastatic prostate cancer to the penis
by: Nicolas Martz, et al.
Published: (2021-10-01) -
Oligometastatic Adenocarcinoma of the Esophagus: Current Understanding, Diagnosis, and Therapeutic Strategies
by: Michael P. Rogers, et al.
Published: (2021-08-01)